1-4 of 4
William Walsh, MD
Close
Sort by
Journal Articles

Reduced Intensity Allogeneic Transplantation Provides High Disease-Free and Overall Survival in Patients (Pts) with Advanced Indolent NHL and CLL: CALGB 109901.

Thomas C. Shea, MD, Jeffrey Johnston, MA, William Walsh, MD, Sherif Farag, MD, PhD, John McCarty, MD, Asad Bashey, MD, PhD, Luis Isola, MD, Marc Stewart, MD, Michael Kelly, MA, Kouros Owzar, PhD, Charles Linker, MD
Journal: Blood
Blood (2007) 110 (11): 486.
https://doi.org/10.1182/blood.V110.11.486.486
Published: 2007
Journal Articles

Myelodysplasia after Autologous Stem Cell Transplantation for Multiple Myeloma.

Gregory Franz, MD, Brian McClune, DO, Francis Buadi, MD, William Walsh, MD, Frank White, MD, Donna Przepiorka, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5329.
https://doi.org/10.1182/blood.V108.11.5329.5329
Published: 2006
Journal Articles

Natural History of Relapse after Autologous Stem Cell Transplantation for Multiple Myeloma.

Brian McClune, DO, Francis Buadi, MD, Furhan Yunus, MD, Sohail Minhas, MD, William Walsh, MD, Donna Przepiorka, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5511.
https://doi.org/10.1182/blood.V106.11.5511.5511
Published: 2005
Journal Articles

Race Has No Effect on Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.

Francis Buadi, MD, Brian McClune, MD, Yoriann Moore, Robin Womeodu, MD, Furhan Yunus, MD, William Walsh, MD, Sohail Minhas, MD, Donna Przepiorka, MD
Journal: Blood
Blood (2004) 104 (11): 5242.
https://doi.org/10.1182/blood.V104.11.5242.5242
Published: 2004